IGC Pharma Inc (IGC)
0.3525
+0.02
(+5.76%)
USD |
NYAM |
Nov 21, 16:00
0.3561
0.00 (0.00%)
After-Hours: 20:00
IGC Pharma Price to Book Value: 3.701 for Nov. 21, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 21, 2024 | 3.701 |
| November 20, 2024 | 3.499 |
| November 19, 2024 | 3.602 |
| November 18, 2024 | 3.685 |
| November 15, 2024 | 3.559 |
| November 14, 2024 | 3.755 |
| November 13, 2024 | 3.855 |
| November 12, 2024 | 4.001 |
| November 11, 2024 | 3.990 |
| November 08, 2024 | 4.010 |
| November 07, 2024 | 4.032 |
| November 06, 2024 | 3.935 |
| November 05, 2024 | 3.958 |
| November 04, 2024 | 3.914 |
| November 01, 2024 | 4.003 |
| October 31, 2024 | 4.050 |
| October 30, 2024 | 4.143 |
| October 29, 2024 | 4.114 |
| October 28, 2024 | 4.207 |
| October 25, 2024 | 4.113 |
| October 24, 2024 | 4.052 |
| October 23, 2024 | 4.102 |
| October 22, 2024 | 4.271 |
| October 21, 2024 | 4.154 |
| October 18, 2024 | 4.057 |
| Date | Value |
|---|---|
| October 17, 2024 | 4.162 |
| October 16, 2024 | 4.228 |
| October 15, 2024 | 3.896 |
| October 14, 2024 | 3.798 |
| October 11, 2024 | 3.793 |
| October 10, 2024 | 3.843 |
| October 09, 2024 | 3.765 |
| October 08, 2024 | 3.791 |
| October 07, 2024 | 3.854 |
| October 04, 2024 | 3.849 |
| October 03, 2024 | 3.761 |
| October 02, 2024 | 4.005 |
| October 01, 2024 | 4.003 |
| September 30, 2024 | 4.435 |
| September 27, 2024 | 3.399 |
| September 26, 2024 | 3.360 |
| September 25, 2024 | 3.276 |
| September 24, 2024 | 3.299 |
| September 23, 2024 | 3.294 |
| September 20, 2024 | 3.378 |
| September 19, 2024 | 3.347 |
| September 18, 2024 | 3.264 |
| September 17, 2024 | 3.373 |
| September 16, 2024 | 3.374 |
| September 13, 2024 | 3.42 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.3983
Minimum
Mar 18 2020
6.550
Maximum
Feb 10 2021
2.038
Average
1.711
Median
Price to Book Value Benchmarks
| CEL-SCI Corp | 4.387 |
| AIM ImmunoTech Inc | 4.631 |
| NovaBay Pharmaceuticals Inc | 3.299 |
| Protalix BioTherapeutics Inc | 3.768 |
| Palatin Technologies Inc | -- |
Price to Book Value Related Metrics
| PS Ratio | 20.62 |
| Price | 0.3525 |
| Earnings Yield | -51.06% |
| Market Cap | 27.30M |